Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4370)
All Articles published online
|
Jun 21, 2010 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Muntoni S, Rojkind M, Muntoni S. Colchicine reduces procollagen III and increases pseudocholinesterase in chronic liver disease. World J Gastroenterol 2010; 16(23): 2889-2894 [PMID: 20556834 DOI: 10.3748/wjg.v16.i23.2889] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i23/2889.htm |
| Number | Citing Articles |
| 1 |
Qin Chen, Lianyun Chen, Xiafei Wu, Feng Zhang, Huanhuan Jin, Chunfeng Lu, Jiangjuan Shao, Desong Kong, Li Wu, Shizhong Zheng. Dihydroartemisinin prevents liver fibrosis in bile duct ligated rats by inducing hepatic stellate cell apoptosis through modulating the PI3K/Akt pathway. IUBMB Life 2016; 68(3): 220 doi: 10.1002/iub.1478
|
| 2 |
Qi Wang, Xuefei Dai, Wanzhi Yang, He Wang, Han Zhao, Feng Yang, Yan Yang, Jun Li, Xiongwen Lv. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP/PKA/CREB pathway in rat hepatic stellate cells. International Immunopharmacology 2015; 25(2): 340 doi: 10.1016/j.intimp.2015.02.012
|
| 3 |
Ying Ying Leung, Laura Li Yao Hui, Virginia B. Kraus. Colchicine—Update on mechanisms of action and therapeutic uses. Seminars in Arthritis and Rheumatism 2015; 45(3): 341 doi: 10.1016/j.semarthrit.2015.06.013
|
| 4 |
Ralf Weiskirchen. Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step. Frontiers in Pharmacology 2016; 6 doi: 10.3389/fphar.2015.00303
|
| 5 |
|
| 6 |
Alaa El-Din El-Sayed El-Sisi, Samia Salim Sokar, Dina Zakaria Mohamed. Dietary Interventions in Liver Disease. 2019; : 15 doi: 10.1016/B978-0-12-814466-4.00002-1
|
| 7 |
Xiao‐ling Zhang, Xiao‐yan Zhang, Xiao‐qun Ge, Ming‐xuan Liu. Mangiferin prevents hepatocyte epithelial‐mesenchymal transition in liver fibrosis via targeting HSP27‐mediated JAK2/STAT3 and TGF‐β1/Smad pathway. Phytotherapy Research 2022; 36(11): 4167 doi: 10.1002/ptr.7549
|
| 8 |
Gamal Esmat, Maissa El Raziky. Cirrhosis: A practical guide to management. 2015; : 274 doi: 10.1002/9781118412640.ch24
|
| 9 |
Hiroshi Fukui, Hidetsugu Saito, Yoshiyuki Ueno, Hirofumi Uto, Katsutoshi Obara, Isao Sakaida, Akitaka Shibuya, Masataka Seike, Sumiko Nagoshi, Makoto Segawa, Hirohito Tsubouchi, Hisataka Moriwaki, Akinobu Kato, Etsuko Hashimoto, Kojiro Michitaka, Toshikazu Murawaki, Kentaro Sugano, Mamoru Watanabe, Tooru Shimosegawa. Evidence-based clinical practice guidelines for liver cirrhosis 2015. Journal of Gastroenterology 2016; 51(7): 629 doi: 10.1007/s00535-016-1216-y
|
| 10 |
Xiaojing Zhu, Feng Zhang, Liang Zhou, Desong Kong, Li Chen, Yin Lu, ShiZhong Zheng. Diallyl trisulfide attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic oxidative stress in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2014; 387(5): 445 doi: 10.1007/s00210-014-0959-3
|
| 11 |
Fatma İlknur Varol, Yılmaz Tabel, Saim Yoloğlu, Elif Yeşilada. Prevalence of Familial Mediterranean Fever in Children with Cryptogenic Cirrhosis. Journal of Tropical Pediatrics 2021; 67(3) doi: 10.1093/tropej/fmab019
|
| 12 |
Lars G Hemkens, Hannah Ewald, Viktoria L Gloy, Armon Arpagaus, Kelechi K Olu, Mark Nidorf, Dominik Glinz, Alain J Nordmann, Matthias Briel. Colchicine for prevention of cardiovascular events. Cochrane Database of Systematic Reviews 2016; doi: 10.1002/14651858.CD011047.pub2
|
| 13 |
Ji Wang, Wen Pan, Ying Wang, Wan Lei, Bin Feng, Caigan Du, Xiao-juan Wang. Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis. Drug Delivery 2018; 25(1): 1 doi: 10.1080/10717544.2017.1399301
|
| 14 |
Moon-Sun Kim, Madeleine Ong, Xianqin Qu. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?. World Journal of Gastroenterology 2016; 22(1): 8-23 doi: 10.3748/wjg.v22.i1.8
|
| 15 |
Francesca Saffioti, Kurinchi Selvan Gurusamy, Leonardo Henry Eusebi, Emmanuel Tsochatzis, Brian R Davidson, Douglas Thorburn. Pharmacological interventions for primary biliary cholangitis. Cochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD011648.pub2
|
| 16 |
Hassan Farghali, Nikolina Kutinová Canová, Samir Zakhari. Hepatoprotective properties of extensively studied medicinal plant active constituents: Possible common mechanisms. Pharmaceutical Biology 2015; 53(6): 781 doi: 10.3109/13880209.2014.950387
|
| 17 |
Durga Prasanna Misra, Armen Yuri Gasparyan, Olena Zimba. Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatology International 2020; 40(11): 1741 doi: 10.1007/s00296-020-04694-2
|
| 18 |
Zeyuan Wang, Xiaoman Zu, Shanshan Xiong, Ren Mao, Yun Qiu, Baili Chen, Zhirong Zeng, Minhu Chen, Yao He. The Role of Colchicine in Different Clinical Phenotypes of Behcet Disease. Clinical Therapeutics 2023; 45(2): 162 doi: 10.1016/j.clinthera.2023.01.004
|
| 19 |
Saloni Sinha, Nora Hassan, Robert E. Schwartz. Organelle stress and alterations in interorganelle crosstalk during liver fibrosis. Hepatology 2024; 79(2): 482 doi: 10.1097/HEP.0000000000000012
|
| 20 |
Rami Abu Fanne, Emad Maraga, Eiass Kassem, Gabriel Groisman, Naama Amsalem, Abdel-Rauf Zeina, Moran Abu Mouch, Randa Taher, Saif Abu-Mouch. Human Neutrophil α-Defensins 1–3 Are Upregulated in the Microenvironment of Fibrotic Liver. Medicina 2023; 59(3): 496 doi: 10.3390/medicina59030496
|
| 21 |
Fatih Unal, Murat Cakir, Masallah Baran, Cigdem Arıkan, Hasan Ali Yuksekkaya, Sema Aydoğdu. Liver involvement in children with Familial Mediterranean fever. Digestive and Liver Disease 2012; 44(8): 689 doi: 10.1016/j.dld.2012.01.003
|